Presenilins interact with armadillo proteins including neural- specific plakophilin-related protein and β-catenin

Journal of Neurochemistry

Volumn 72, Issue 3, 1999, Pages 999-1008

  Levesque, G ^a,b   Yu, G ^a,b   Nishimura, M ^a,b   Zhang, D M ^a,b   Levesque, L ^a,b   Yu, H ^a,b   Xu, D ^a,b   Liang, Y ^a,b   Rogaeva, E ^a,b   Ikeda, M ^a,b   Duthie, M ^a,b   Murgolo, N ^c   Wang, L ^c   VanderVere, P ^c   Bayne, M L ^c   Strader, C D ^c   Rommens, J M ^a,b,d   Fraser, P E ^a,b   St George Hyslop, P ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MERCK RESEARCH LABORATORIES   (United States)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Alzheimer's disease; Armadillo proteins; Presenilin binding proteins; Presenilin proteins; Yeast two hybrid

Indexed keywords

BETA CATENIN; BINDING PROTEIN; COMPLEMENTARY DNA; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; ARTICLE; DNA HYBRIDIZATION; DNA LIBRARY; HUMAN; HUMAN CELL; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; ARMADILLO DOMAIN PROTEINS; BETA CATENIN; CATENINS; CELL ADHESION MOLECULES; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; CYTOSKELETAL PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; PLAKOPHILINS; PRECIPITIN TESTS; PRESENILIN-1; PRESENILIN-2; PROTEIN BINDING; TRANS-ACTIVATORS; TRANSFECTION;

ARMADILLO; SACCHAROMYCES CEREVISIAE;

EID: 0032972547     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720999.x     Document Type: Article

References (44)

1. Barth A. I., Nathke I. S., and Nelson W. J. (1997) Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signalling pathways. Curr. Opin. Cell Biol. 9, 683-690.
2. Borchelt D. R., Thinakaran G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky T., Prada C. M., Kim G., Seekins S., Yager D., Slunt H. H., Wang R., Seeger M., Levey A. I., Gandy S. E., Copeland N. G., Jenkins N. A., Price D. L., Younkin S. G., and Sisodia S. S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abetal-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
3. Boulianne G., Livne-Bar I., Humphreys J. M., Rogaev E., and St. George-Hyslop P. (1997) Cloning and mapping of a close homologue of human presenilins in D. melanogaster. Neuroreport 8, 1025-1029.
4. Cadigan K. M. and Nusse R. (1997) Wnt signalling: a common theme in animal development. Genes Der. 11, 3286-3305.
5. Citron M., Westaway D., Xia W., Carlson G., Diehl T. S., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St. George-Hyslop P., and Selkoe D. J. (1997) Mutant presenilins of Alzheimer's disease increase production of 42 residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67-72.
6. De Strooper B., Beullens M., Contreras B., Craessaerts K., Moechars D., Bollen M., Fraser P., St. George-Hyslop P., and Van Leuven F. (1997) Posttranslational modification, subcellular localization and membrane orientation of the Alzheimer's disease associated presenilins. J. Biol. Chem. 272, 3590-3598.
7. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., and Van Leuven F. (1998) Deficiency of presenilin 1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387-390.
8. Deng G., Pike C. J., and Cotman C. W. (1996) Alzheimer-associated presenilin 2 confers increased sensitivity to apoptosis in PC 12 cells. FEBS Lett. 397, 50-54.
9. Doan A., Thinakaran G., Borchelt D. R., Slunt H. H., Ratovitsky T., Podlisny M., Selkoe D. J., Seeger M., Gandy S. E., Price D. L., and Sisodia S. S. (1996) Protein topology of presenilin 1. Neuron 17, 1023-1030.
10. Duff K., Eckman C., Zehr C., Yu X., Prada C. H., Perez-Tur J., Hutton M., Refolo L., Zenk B., Hardy J., and Younkin S. (1996) Increased amyloid beta 42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
11. Gumbiner B. M. (1995) Signal transduction by beta-catenin. Curr. Opin. Cell Biol. 7, 634-640.
12. Harlow E. and Lane D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
13. Hatzfeld M. and Nachtstein C. (1996) Cloning and characterization of a new armadillo protein family member, p0071, associated with junctional plaques: evidence for a subfamily of closely related proteins. J. Cell Sci. 109, 2767-2778.
14. Hong M., Chen D. C., Klein P. S., and Lee V. M. (1997) Lithium reduces Tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 272, 25326-25332.
15. Imahori K. and Uchida T. (1997) Physiology and pathology of Tau protein kinases in relation to Alzheimer's disease. J. Biochem. (Tokyo) 121, 179-188.
16. Jellinger K. A. (1996) Structural basis of dementia in neurodegenerative disorders. J. Neural Transm. Suppl. 47, 1-29.
17. Lee M. K., Slunt H. H., Martin L. J., Thinakaran G., Kim G., Gandy S. E., Seeger M., Koo M., Price D. L., and Sisodia S. S. (1996) Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J. Neurosci. 16, 7513-7525.
18. Lehmann S., Chiesa R., and Harris D. A. (1997) Evidence for a six transmembrane domain structure for PS1. J. Biol. Chem. 272, 12047-12051.
19. Levitan D. and Greenwald I. (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354.
20. Levy-Lahad E., Wijsman E. M., Nemans E., Anderson L., Goddard K. A., Weber J. L., Bird T. D., and Schellenberg G. D. (1995) A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973.
21. Li J., Xu M., Zhou H., Ma J., and Potter H. (1997) Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centromeres suggest a role in chromosome segregation. Cell 90, 917-927.
22. Martins R. N., Turner B. A., Carroll R. T., Sweeney D., Kim K. S., Wisniewski H. M., Blass J. P., Gibson G. E., and Gandy S. E. (1995) High levels of amyloid beta-protein from S182 (Glu246) familial Alzheimer's cells. Neuroreport 7, 217-220.
23. Masliah E. and Terry R. D. (1993) The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol. 3, 77-85.
24. Nishimura M., Yu G., Levesque G., Zhang D. M., Ruel L., Chen F., Millman P., Holmes E., Liang Y., Kawarai T., Jo E., Supala A., Rogaeva E., Xu D.-M., Janus C., Levesque L., Bi Q., Duthie M., Rozmahel R., Mattila K., Lannfelt L., Westaway D., Mount H. T. J., Woodgett J., Fraser P. E., and St. George-Hyslop P. (1999) Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin - a component of the presenilin protein complex. Nat. Med. (in press).
25. Paffenholz R. and Franke W. W. (1997) Identification and localization of a neurally expressed member of the plakoglobin/armadillo multigene family. Differentiation 61, 293-304.
26. Perez-Tur J., Froelich S., Prihar G., Crook R., Baker M., Duff K., Wragg M., Hardy J., Goate A., Lannfelt L., and Hutton M. (1996) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin 1 gene. Neuroreport 7, 297-301.
27. 299 and occur as stable N-and C-terminal fragments in normal brain tissue. Neurobiol. Dis. 3, 325-337.
28. Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lannfelt L., Fraser P. E., Rommens J. M., and St. George-Hyslop P. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
29. Rogaev E. I., Sherrington R., Wu C., Levesque G., Liang Y., Rogaeva E. A., Chi H., Ikeda M., Holman K., Lin C., Lukiw W. J., de Jong P. J., Fraser P. E., Rommens J. M., and St. George-Hyslop P. H. (1997) Analysis of the 5′ sequence, genomic structure and alternative splicing of the presenilin 1 gene associated with early onset Alzheimer's disease. Genomics 40, 415-424.
30. Sato S., Kamino K., Miki T., Doi A., Ii K., St. George-Hyslop P., Ogihara T., and Sakaki Y. (1998) Splicing mutation of presenilin 1 gene for early onset familial Alzheimer's disease. Hum. Mutat. (Suppl.), S91-S94.
31. Scheuner D., Eckman L., Jensen M., Sung X., Citron M., Suzuki N., Bird T., Hardy J., Hutton M., Lannfelt L., Selkoe D., and Younkin S. (1996) Secreted amyloid-β protein similar to that in the senile plaques of Alzheimer disease is increased in vivo by presenilin 1 and 2 and APP mutations linked to FAD. Nat. Med. 2, 864-870.
32. Shen J., Bronson R. T., Chen D. F., Xia W., Selkoe D. S., and Tonegawa S. (1997) Skeletal and CNS defects in presenilin-1 deficient mice. Cell 89, 629-639.
33. Sherrington R., Rogaev E., Liang Y., Rogaeva E., Levesque G., Ikeda M., Chi H., Lin C., Holman K., Tsuda T., Mar L., Fraser P., Rommens J. M., and St. George-Hyslop P. (1995) Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 375, 754-760.
34. Sonnhammer E. L. L. and Kahn D. (1994) Modular arrangement of proteins as inferred from analysis of homology. Protein Sci. 3, 482-492.
35. Sperber B. R., Leight S., Goedert M., and Lee V. M. (1995) Glycogen synthase kinase 3 beta phosphorylates Tau protein at multiple sites in intact cells. Neurosci. Lett. 197, 149-153.
36. Staddon J. M., Smales C., Schulze C., Esch F. S., and Rubin L. L. (1995) p120, a p120-related protein (p100) and the cadherin/ catenin complex. J. Cell Biol. 130, 369-381.
37. Takashima A., Murayama M., Murayama O., Kohno T., Honda T., Yasutake K., Nihonmatsu N., Mercken M., Yamaguchi H., Sugihara S., and Wolozin B. (1998) Presenilin 1 associates with glycogen synthase kinase 3 beta and its substrate Tau. Proc. Natl. Acad. Sci. USA 95, 9637-9641.
38. Thinakaran G., Borchelt D. R., Lee M. K., Slunt H. H., Spitzer L., Kim G., Ratovisky T., Davenport F., Nordstedt C., Seeger M., Levey A. I., Gandy S. E., Jenkins N. A., Copeland N., Price D. L., and Sisodia S. S. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190.
39. ++ binding protein Alg-2 and Alzheimer's disease gene Alg-3. Science 271, 521-525.
40. Walter J., Capell A., Grunberg J., Pesold B., Schindzielorz A., Prior R., Podlisny M. B., Fraser P., St. George-Hyslop P., Selkoe D., and Haass C. (1996) The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med 2, 673-691.
41. Wolozin B., Iwasaki K., Vito P., Ganjei K., Lacana E., Sunderland T., Zhao B., Kusiak J. W., and D'Adamio L. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713.
42. Wong P. C., Zheng H., Chen H., Becher M. W., Sirinathsinghji D. J., Trumbauer M. E., Chen H. Y., Price D. L., Van Der Ploeg L. H., and Sisodia S. S. (1997) Presenilin 1 is required for Notch and D111 expression in the paraxial mesoderm. Nature 387, 288 -292.
43. Yu G., Chen F., Levesque G., Nishimura M., Zhang D.-M., Levesque L., Rogaeva E., Xu D., Liang Y., Duthie M., St. George-Hyslop P., and Fraser P. E. (1998) The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin. J. Biol. Chem. 273, 16470-16475.
44. Zhou J., Liyanage U., Medina M., Ho C., Simmons A. D., Lovett M., and Kosik K. S. (1997) Presenilin 1 interacts with a novel member of the armadillo family. Neuroreport 8, 2085-2090.